Nasdaq GlobeNewswire

SolarWinds Cloud Portfolio Enhancements Strengthen Capabilities for Both Infrastructure and Application Monitoring

Del

Tighter integration and new features empower users to monitor more hosts and more applications, more affordably

AUSTIN, Texas, June 05, 2018 (GLOBE NEWSWIRE) -- SolarWinds, a leading provider of powerful and affordable IT management software, today announced significant enhancements across its SolarWinds Cloud®portfolio of SaaS-based products, including updates to AppOptics(TM), Pingdom®, Papertrail(TM), and Loggly® offerings. These SolarWinds Cloud enhancements are designed to deepen visibility across both cloud infrastructure and applications to simplify full-stack monitoring for DevOps and IT Ops professionals and enable a more integrated user experience for customers using more than one product.

New Features and Capabilities for AppOptics, Pingdom, Papertrail, and Loggly
Specific enhancements that broaden infrastructure and application monitoring support and enhance simplicity include:

  • AppOptics - Now offers a unified view to quickly identify outliers and usage patterns through new host map and host list view capabilities. Support for seven programming languages, now including Ruby, Go, and Node.js®, enables deeper visibility into infrastructure and applications. The AppOptics integration with Papertrail and Loggly makes logs available to provide contextual information for troubleshooting.
  • Pingdom - Now provides up to 13 months of data to deepen digital experience monitoring. In addition, users can now generate shareable online reports to effectively communicate across teams. 
  • Papertrail - Adds a new event viewer, new velocity graphs, and dashboard improvements to accelerate troubleshooting.
  • Loggly - Now offers preconfigured dashboards based on log types to simplify monitoring across complex environments. 

"The power of Papertrail is in its simplicity," said Dave North, director of DevOps at Signiant, a U.S.-based media and entertainment company. "The new features build on the product's usability and add real value. For example, being able to favorite groups in the dashboard saves me time. The new velocity graphs are especially valuable, as they let us visualize the error rate, and quickly determine whether we have a small or large problem."

In addition to these new features, tighter integration within the portfolio can give users the ability to cross-launch among SolarWinds Cloud products. This means DevOps professionals can now easily move from a dashboard that highlights load time issues on a web page, for example, into a detailed log view to troubleshoot an application infrastructure issue. 

"It is too hard and expensive for DevOps and IT Ops professionals to comprehensively monitor the performance of modern applications in their environment," said Christoph Pfister, executive vice president of products, SolarWinds. "The release today extends our comprehensive monitoring capabilities across infrastructure and applications. Using these powerful, affordable products, our customers will see the full picture of traces, metrics, logs, and the digital experience, improving the responsiveness of their applications and making their lives much easier."

The SolarWinds Cloud enhancements are the latest milestones in the company's drive to deliver a set of comprehensive, simple, and affordable full-stack monitoring solutions. SolarWinds' goal is to enable a single view of infrastructure, applications, and digital experience, which will help customers solve their most complex performance and reliability problems quickly, simply, and affordably.

Pricing and Availability
The enhanced SolarWinds Cloud offerings are available immediately. Pricing starts at $7.50 per month for AppOptics, $9.95 per month for Pingdom, $7.00 per month for Papertrail, and $99.00 per month for Loggly.

*Prices as of June 4, 2018 in U.S. dollars. Pricing may vary based upon the jurisdiction and applicable currency. Please contact a local SolarWinds sales representative to find pricing specific to your jurisdiction.

Additional Resources

Connect with SolarWinds

About SolarWinds

SolarWinds provides powerful and affordable IT management software to customers worldwide, from Fortune 500® enterprises to small businesses, managed service providers (MSPs), government agencies, and educational institutions. We are committed to focusing exclusively on IT, MSP, and DevOps professionals, and strive to eliminate the complexity that our customers have been forced to accept from traditional enterprise software vendors. Regardless of where the IT asset or user sits, SolarWinds delivers products that are easy to find, buy, use, maintain, and scale while providing the power to address key areas of the infrastructure from on-premises to the cloud. This focus and commitment to excellence in end-to-end hybrid IT performance management has established SolarWinds as the worldwide leader in both network management software and MSP solutions, and is driving similar growth across the full spectrum of IT management software. Our solutions are rooted in our deep connection to our user base, which interacts in our THWACK online community to solve problems, share technology and best practices, and directly participate in our product development process. Learn more today at www.solarwinds.com.

The SolarWinds, SolarWinds Cloud, AppOptics, Pingdom, Papertrail and Loggly trademarks are the exclusive property of SolarWinds Worldwide, LLC and its affiliates and may be registered or pending registration with the U.S. Patent and Trademark Office and in other countries. All other SolarWinds, SolarWinds Cloud, AppOptics, Pingdom, Papertrail and Loggly trademarks, service marks, and logos may be common law marks or are registered or pending registration. All other trademarks mentioned herein are used for identification purposes only and are trademarks (and may be registered trademarks) of their respective companies.

© 2018 SolarWinds Worldwide, LLC. All rights reserved.

MEDIA CONTACTS:  
Nicole Fachet  Jenne Barbour
Text100    SolarWinds
Phone: 212.871.3950    Phone: 512.498.6804
NicoleF@text100.com pr@solarwinds.com

Images accompanying this announcement are available at
http://www.globenewswire.com/NewsRoom/AttachmentNg/31367a28-0207-4623-8c0e-ae72248aa505 
http://www.globenewswire.com/NewsRoom/AttachmentNg/51a89363-8c54-4dc3-8232-f493badd97b3 
http://www.globenewswire.com/NewsRoom/AttachmentNg/7149ed36-289a-46d4-bf23-af6194dfd651 
http://www.globenewswire.com/NewsRoom/AttachmentNg/7d960952-88d7-490e-a3d2-c0e1dba8652b 
http://www.globenewswire.com/NewsRoom/AttachmentNg/787d8308-4121-4710-bf83-b1af78f7a641




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: SolarWinds Worldwide, LLC via Globenewswire

Om Nasdaq GlobeNewswire

Nasdaq GlobeNewswire
Nasdaq GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

+1 212 401 8700http://www.nasdaqomx.com

NASDAQ (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.

Følg saker fra Nasdaq GlobeNewswire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Nasdaq GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Nasdaq GlobeNewswire

Primal Pictures Partners with Physitrack to Create a Unique Patient Education Solution25.6.2018 18:00Pressemelding

LONDON, June 25, 2018 (GLOBE NEWSWIRE) -- Today, Primal Pictures, pioneer of the world's most medically-accurate and detailed 3D models of human anatomy, and Physitrack, the market-leading patient engagement and Telehealth solution provider, announce their partnership on a unique anatomically augmented home exercise and patient education feature. The feature inside Physitrack, which is powered by Primal Pictures, will allow healthcare practitioners to better educate their patients, and therefore help patients to improve their health outcomes. "Even the best physical therapy regime will be unsuccessful without proper patient education," explained Henrik Molin, CEO and co-founder of Physitrack. "That's why Physitrack developed what has become the industry's gold standard in patient engagement and outcome tracking. With Primal Pictures, we saw the opportunity to take our solution to a new level by helping patients make the connection between their physical therapy regime and the anatomy i

EPAM's InfoNgen(TM) Debuts With Highest Score Possible in Seven Criteria in AI-Based Text Analytics Platforms Report by Independent Research Firm25.6.2018 16:58Pressemelding

InfoNgen, categorized as one of the top eight providers that matter most, is a fully integrated, end-to-end turnkey solution that helps enterprises become more insights-driven NEWTOWN, Pa., June 25, 2018 (GLOBE NEWSWIRE) -- EPAM Systems, Inc. (NYSE:EPAM), a leading global provider of digital platform engineering and software development services, today announced that it has been named a Contender in the report "The Forrester Wave(TM): AI-Based Text Analytics Platforms, Q2 2018" for its product InfoNgen(TM). InfoNgen ranked among the highest scores in the enterprise features, RPA functionality, training data for machine learning, focus on cloud and SaaS, and overall revenue criteria. According to the report, "[EPAM's] InfoNgen text analytics product is a good example of how modern consulting firms and systems integrators differentiate - they productize solutions." "EPAM's inclusion in this report, along with leaders like IBM and SAS, demonstrates, in our opinion, our ability to extend e

Align Technology Reaches One Millionth Invisalign(R) Patient in the EMEA Region25.6.2018 16:00Pressemelding

Milestone Reflects Accelerating Adoption of Invisalign Treatment Among Adults and Teens in Europe SAN JOSE, Calif. and AMSTERDAM, The Netherlands, June 25, 2018 (GLOBE NEWSWIRE) -- Align Technology, Inc. (Nasdaq:ALGN), today announced that it shipped its one millionth Invisalign case for the EMEA region in April, 2018. This significant milestone for the company and the more than 34 thousand Invisalign-trained orthodontists and general dentists in the region reflects accelerating adoption of Invisalign clear aligner therapy in Europe, Middle East and Africa. "I am immensely proud to announce that we have reached yet another significant milestone for EMEA with our one millionth Invisalign patient in the region. The demand and adoption rate for Invisalign clear aligners in EMEA has accelerated rapidly during recent years. I would like to thank our doctors for their trust and confidence in treating patients with the Invisalign system, and acknowledge the more than one million patients in E

Novelion Therapeutics Announces Presentation of Positive Metreleptin Data at American Diabetes Association Scientific Sessions25.6.2018 14:00Pressemelding

Data Show Leptin Replacement Therapy Sustainably Decreased Weight Over Time in Patients with Low Baseline Leptin Levels Company plans to initiate Phase 2 proof of concept study in hypoleptinemic metabolic disorder (HMD) by year-end VANCOUVER, British Columbia, June 25, 2018 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ:NVLN), a biopharmaceutical company dedicated to developing and commercializing therapies for individuals living with rare diseases, today announced that clinical data from a metreleptin study assessing weight loss in overweight and obese adults with low leptin levels will be featured in a poster presentation at the American Diabetes Association's (ADA) 78th Scientific Sessions, being held June 22-26, 2018 in Orlando. The study, titled "Efficacy of Metreleptin for Weight Loss in Overweight and Obese Adults With Low Leptin Levels," was conducted in adults with low baseline leptin, defined as <16 ng/mL in females and <5 ng/mL in males, and Body Mass Index (BMI) lev

ERYTECH Confirms Strategic Focus of Eryaspase on Solid Tumors and Ceases Development in Acute Lymphoblastic Leukemia25.6.2018 00:06Pressemelding

Conference call on Monday, June 25th at 2:30 pm CET/8:30 am EDT Focuses development efforts on solid tumor indications Confirms planned launch of company-sponsored randomized Phase 2 trial in first-line pancreatic cancer, in addition to ongoing launch of Phase 3 trial in second-line pancreatic cancer. Expands eryaspase production capacity in the United States and France Plans to cease development in acute lymphoblastic leukemia (ALL), including withdrawal of European Marketing Authorization Application (MAA) LYON, France and CAMBRIDGE Mass., June 24, 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext:ERYP) (Nasdaq:ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announced that it will focus its development efforts for its product candidate eryaspase on the potential treatment of selected solid tumor indications. The company also announced that it plans to cease its development pro

CORRECTING and REPLACING -- PRESS ALERT & INVITATION: Arbitrade to Hold a Press Conference on June 28th From Bermuda - Its New Global Headquarters23.6.2018 14:00Pressemelding

NEW YORK, June 23, 2018 (GLOBE NEWSWIRE) -- In a press release issued under the same headline earlier today by Arbitrade, please note that the correct date of the event is Thursday, June 28, 2018 at 8:00 a.m. EDT. The corrected release follows: This is an invitation to all media following Arbitrade and/or covering the cryptocurrency markets. You are invited to join Arbitrade's Chairman, Len Schutzman, and management who will discuss their progress toward establishing Arbitrade as a world-class cryptocurrency exchange and coin company. They will also discuss their move and incorporation into Bermuda, one of the world's best regulated jurisdictions and a platform from which Arbitrade will reach out to several international markets. It will be a lively discussion that will also include details of the many economic and social advantages and new jobs that companies, like Arbitrade, will bring to countries in which they settle and do business around the world. Details of how to access the pr

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom